ARCHIVES

J&J Withdraws Power Morcellators, Citing Risk of Disseminating Cancer

This article is from The Cancer Letter archive.

Vol. 40 No. 31 | August 1, 2014

Download PDF Visit The Full Archive

Related Articles

NCI’s Schneiderman Reports Result Of Better Treatment, Some Drop In Incidence, Overall Increase As Kennedy Hearings Open

March 9, 1979

Report Questions Effectiveness Of Bimanual Pelvic Exam

March 31, 2006

Two Drugs Combined Better Than One Alone, Study Finds

February 27, 2009

Managed Care: “Natural Alliance” Between Managed Care And Academic Centers, McGivney Says

January 24, 1997

NCI Staff Suggest New Community Oncology, Pain Control, Nurse, Pathology Center Projects

May 13, 1977

Afatinib Delays Tumor Growth In LUX-Head and Neck 1 Study

October 31, 2014